Search Keyword:


Search option:


IID00534
UniprotP01137
ProteinTransforming growth factor beta-1
GeneTGFB1
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
390
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 30-390 Monomer :
 Evidence X-RAY 5vqp A Reference
       Region 5vqp A 30-31 disorder
       Region 5vqp A 32-68 order
       Region 5vqp A 69-70 disorder
       Region 5vqp A 71-90 order
       Region 5vqp A 91-100 disorder
       Region 5vqp A 101-271 order
       Region 5vqp A 272-279 disorder
       Region 5vqp A 280-327 order
       Region 5vqp A 328-339 disorder
       Region 5vqp A 340-342 order
       Region 5vqp A 343-347 disorder
       Region 5vqp A 348-390 order
Seq 34-390 Hetero octamer : P06756,P18564
 Evidence X-RAY 5ffo H Reference
       Region 5ffo H 34-90 order
       Region 5ffo H 91-98 disorder
       Region 5ffo H 99-269 order
       Region 5ffo H 270-287 disorder
       Region 5ffo H 288-333 order
       Region 5ffo H 334-338 disorder
       Region 5ffo H 339-370 order
       Region 5ffo H 371-371 disorder
       Region 5ffo H 372-390 order
 Evidence X-RAY 5ffo G Reference
       Region 5ffo G 34-38 disorder
       Region 5ffo G 39-64 order
       Region 5ffo G 65-66 disorder
       Region 5ffo G 67-89 order
       Region 5ffo G 90-100 disorder
       Region 5ffo G 101-225 order
       Region 5ffo G 226-234 disorder
       Region 5ffo G 235-269 order
       Region 5ffo G 270-278 disorder
       Region 5ffo G 279-328 order
       Region 5ffo G 329-352 disorder
       Region 5ffo G 353-390 order
 Evidence X-RAY 5ffo D Reference
       Region 5ffo D 34-35 disorder
       Region 5ffo D 36-91 order
       Region 5ffo D 92-98 disorder
       Region 5ffo D 99-226 order
       Region 5ffo D 227-230 disorder
       Region 5ffo D 231-269 order
       Region 5ffo D 270-284 disorder
       Region 5ffo D 285-332 order
       Region 5ffo D 333-338 disorder
       Region 5ffo D 339-370 order
       Region 5ffo D 371-371 disorder
       Region 5ffo D 372-390 order
 Evidence X-RAY 5ffo C Reference
       Region 5ffo C 34-36 disorder
       Region 5ffo C 37-89 order
       Region 5ffo C 90-100 disorder
       Region 5ffo C 101-225 order
       Region 5ffo C 226-235 disorder
       Region 5ffo C 236-269 order
       Region 5ffo C 270-278 disorder
       Region 5ffo C 279-328 order
       Region 5ffo C 329-347 disorder
       Region 5ffo C 348-390 order
Seq 279-390 Homo dimer :
 Evidence NMR 1kla A Reference
       Region 1kla A 279-285 order
       Region 1kla A 286-292 disorder
       Region 1kla A 293-306 order
       Region 1kla A 307-317 disorder
       Region 1kla A 318-345 order
       Region 1kla A 346-353 disorder
       Region 1kla A 354-364 order
       Region 1kla A 365-380 disorder
       Region 1kla A 381-390 order
 Evidence NMR 1kla B Reference
       Region 1kla B 279-285 order
       Region 1kla B 286-292 disorder
       Region 1kla B 293-306 order
       Region 1kla B 307-317 disorder
       Region 1kla B 318-345 order
       Region 1kla B 346-353 disorder
       Region 1kla B 354-364 order
       Region 1kla B 365-380 disorder
       Region 1kla B 381-390 order
 Evidence NMR 1klc A Reference
       Region 1klc A 279-285 order
       Region 1klc A 286-292 disorder
       Region 1klc A 293-306 order
       Region 1klc A 307-317 disorder
       Region 1klc A 318-345 order
       Region 1klc A 346-353 disorder
       Region 1klc A 354-364 order
       Region 1klc A 365-380 disorder
       Region 1klc A 381-390 order
 Evidence NMR 1klc B Reference
       Region 1klc B 279-285 order
       Region 1klc B 286-292 disorder
       Region 1klc B 293-306 order
       Region 1klc B 307-317 disorder
       Region 1klc B 318-345 order
       Region 1klc B 346-353 disorder
       Region 1klc B 354-364 order
       Region 1klc B 365-380 disorder
       Region 1klc B 381-390 order
 Evidence NMR 1kld A Reference
       Region 1kld A 279-285 order
       Region 1kld A 286-292 disorder
       Region 1kld A 293-306 order
       Region 1kld A 307-317 disorder
       Region 1kld A 318-345 order
       Region 1kld A 346-353 disorder
       Region 1kld A 354-364 order
       Region 1kld A 365-380 disorder
       Region 1kld A 371-374 high_rmsd
       Region 1kld A 381-390 order
 Evidence NMR 1kld B Reference
       Region 1kld B 279-285 order
       Region 1kld B 286-292 disorder
       Region 1kld B 293-306 order
       Region 1kld B 307-317 disorder
       Region 1kld B 318-345 order
       Region 1kld B 346-353 disorder
       Region 1kld B 354-364 order
       Region 1kld B 365-380 disorder
       Region 1kld B 371-374 high_rmsd
       Region 1kld B 381-390 order
 Evidence X-RAY 4kv5 C Reference
       Region 4kv5 C 279-390 order
 Evidence X-RAY 4kv5 D Reference
       Region 4kv5 D 279-390 order
 Evidence X-RAY 4kv5 A Reference
       Region 4kv5 A 279-390 order
 Evidence X-RAY 4kv5 B Reference
       Region 4kv5 B 279-390 order
Seq 279-390 Hetero hexamer : IID00413Complex,IID00414Complex
 Evidence X-RAY 3kfd A Reference
       Region 3kfd A 279-390 order
 Evidence X-RAY 3kfd B Reference
       Region 3kfd B 279-390 order
 Evidence X-RAY 3kfd C Reference
       Region 3kfd C 279-390 order
 Evidence X-RAY 3kfd D Reference
       Region 3kfd D 279-390 order
SeqProS verified 286-292 Hetero hexamer : IID00413Complex,IID00414Complex
       Region 3kfd A 279-390 order
       Region 3kfd B 279-390 order
       Region 3kfd C 279-390 order
       Region 3kfd D 279-390 order
       Region 1kld A 286-292 disorder
 
Prediction
NeProc
Disorder 1-44,83-131,239-288
Order 45-82,132-238,289-390
ProS 6-23,29-44,83-93,101-113,120-131,239-249,256-266,279-288
AlphaFold
Disorder 1-35,66-67,94-102,125-126,240-252,270-291,328-334,350-350
Order 36-65,68-93,103-124,127-239,253-269,292-327,335-349,351-390
Pfam Hmmer
PF00688 33-252 1.1e-72
PF00019 290-390 7.8e-49
SEG 2-23 ,89-101 ,149-162
Function
Function in SwissProt
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells. Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292).